These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18759262)

  • 21. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists.
    Widdifield J; Bernatsky S; Paterson JM; Tu K; Ng R; Thorne JC; Pope JE; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1582-91. PubMed ID: 23592598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and adaptation of a German screening tool to identify patients at risk of juvenile idiopathic arthritis.
    Scheer T; Klotsche J; Len CA; Foeldvari I
    Rheumatol Int; 2020 Apr; 40(4):643-650. PubMed ID: 31667541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis.
    Kaneko S; Shimbo A; Irabu H; Mizuta M; Nakagishi Y; Iwata N; Yokoyama K; Yasumura J; Akamine K; Ueno K; Fujita S; Watanabe K; Watanabe S; Nishikawa H; Fujimura J; Mori M; Shimizu M
    Cytokine; 2024 Oct; 182():156719. PubMed ID: 39084066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
    Edwards CJ; Arden NK; Fisher D; Saperia JC; Reading I; Van Staa TP; Cooper C
    Rheumatology (Oxford); 2005 Nov; 44(11):1394-8. PubMed ID: 16030083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis.
    Saito K; Gabbeta A; Mulvihill E; Al-Jaberi L; Beukelman T; Lewis JD; Rose CD; Strom BL; Horton DB
    Pharmacoepidemiol Drug Saf; 2024 May; 33(5):e5803. PubMed ID: 38685851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus.
    Martini A; Ravelli A; Avcin T; Beresford MW; Burgos-Vargas R; Cuttica R; Ilowite NT; Khubchandani R; Laxer RM; Lovell DJ; Petty RE; Wallace CA; Wulffraat NM; Pistorio A; Ruperto N;
    J Rheumatol; 2019 Feb; 46(2):190-197. PubMed ID: 30275259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.
    Reyhan I; Zhukov OS; Lagier RJ; Bridgforth RF; Williams GJ; Popov JM; Naides SJ; Reiff A
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):14. PubMed ID: 33593401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Utility and Experience with Disease Biomarkers in Juvenile Onset Arthritis vs. Adult Onset Arthritis.
    Patwardhan A
    Cureus; 2019 Jul; 11(7):e5131. PubMed ID: 31341750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage.
    Al-Mayouf SM; Alrasheedi A; Almsellati I; Hashad S; Khawaja K; Abdwani R; AlHashim S; Muzaffer M; Lotfy H; Almutairi N
    Int J Rheum Dis; 2021 Aug; 24(8):1080-1085. PubMed ID: 34184820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance.
    Widdifield J; Bombardier C; Bernatsky S; Paterson JM; Green D; Young J; Ivers N; Butt DA; Jaakkimainen RL; Thorne JC; Tu K
    BMC Musculoskelet Disord; 2014 Jun; 15():216. PubMed ID: 24956925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4).
    Hansell A; Hollowell J; Nichols T; McNiece R; Strachan D
    Thorax; 1999 May; 54(5):413-9. PubMed ID: 10212105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of coeliac disease in patients with rheumatoid arthritis and juvenile idiopathic arthritis: a systematic review and meta-analysis.
    Forss A; Sotoodeh A; van Vollenhoven RF; Ludvigsson JF
    Clin Exp Rheumatol; 2024 Mar; 42(3):608-618. PubMed ID: 37933564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text.
    Ford E; Carroll J; Smith H; Davies K; Koeling R; Petersen I; Rait G; Cassell J
    BMJ Open; 2016 Jun; 6(6):e010393. PubMed ID: 27354069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
    Boyko Y; Hrytsiuk I; Consolaro A; Bovis F; Ruperto N;
    Rheumatol Int; 2018 Apr; 38(Suppl 1):403-409. PubMed ID: 29637352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap.
    Hinks A; Cobb J; Sudman M; Eyre S; Martin P; Flynn E; Packham J; ; ; ; Barton A; Worthington J; Langefeld CD; Glass DN; Thompson SD; Thomson W
    Ann Rheum Dis; 2012 Jul; 71(7):1117-21. PubMed ID: 22294642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients.
    Mannion ML; Xie F; Baddley J; Chen L; Curtis JR; Saag K; Zhang J; Beukelman T
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):49. PubMed ID: 27596158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J; Sitzmann FC
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD.
    Charlton RA; Weil JG; Cunnington MC; de Vries CS
    Drug Saf; 2010 Sep; 33(9):741-50. PubMed ID: 20701407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Patients With Celiac Disease: A Population-Based Cohort Study.
    Doyle JB; Lebwohl B; Askling J; Forss A; Green PHR; Roelstraete B; Söderling J; Ludvigsson JF
    Am J Gastroenterol; 2022 Dec; 117(12):1971-1981. PubMed ID: 36114769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.